Northrop Grumman Deploys Clinical Trials Management System For The Pharmaceutical Industry
Washington, D.C. - Northrop Grumman Corporation has deployed its Global Trials Manager(TM) software system that manages the clinical trials process for the pharmaceutical industry. Northrop Grumman integrated the technological, business and human requirements of the clinical trials industry into a comprehensive solution designed to automate and extend core business processes.
Global Trials Manager manages the clinical trial process at length through Web-based and automated workflow features. Through real-time information sharing among project teams, the system enables quicker decision-making, effective use of resources, reduced time-to-market and enhanced patient safeguards.
Northrop Grumman's Information Technology sector installed the system at ICON Clinical Research, a full-service contract research organization headquartered in Dublin, Ireland. ICON tested the product to validate that it will meet the needs of the pharmaceutical, biotechnology, medical-device and contract-research industries by streamlining information capture, maintaining data relevancy and providing automatic notification.
"The successful delivery of Global Trials Manager to ICON marks a milestone for Northrop Grumman in providing the software to the pharmaceutical market where it will have a significant role in the clinical trials process," said Pat Barrett, life-sciences practice area leader for Northrop Grumman Information Technology.
"Now that we have completed the validation of the Global Trials Manager system, we are excited to begin the rollout to full operations," said Peter Gray, chief executive officer for ICON. "We anticipate great efficiencies both internally and for our customers in the execution of clinical trials and services."
The Global Trials Manager product offers an integrated planning and monitoring environment that simulates all aspects of a clinical trial. The system's functionality supports research study start-up activities, site initiation, patient enrollment and monitoring, data collection throughout the trial, and analysis of project metrics and results. Additional capabilities include real-time reporting and tracking, automated alerts and notifications of tasks, and the ability to search for, identify and respond to key data points. These features allow organizations to more easily and securely make adjustments and changes for a successful trial.
SOURCE: Northrop Grumman Corporation